Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials
Conclusions:
CEE (0.625 mg/d) administered orally, with or without MPA, is associated with an increased risk of hypertension in older postmenopausal women. Whether lower doses, different estrogen formulations, or transdermal route of administration offer lower risks warrant further study.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Hormonal Therapy | Hormones | Hypertension | Hysterectomy | Medroxyprogesterone | Men | Menopause | OBGYN | Study | Women